Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors.
Launched by ABU DHABI HEALTH SERVICES COMPANY · Sep 18, 2024
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Bloodstream bacterial infection is a serious medical problem and one of the leading causes of death worldwide among all age groups. Appropriate and early antibiotic use has been associated with better outcomes based on many clinical trials. On the other hand, misuse and abuse of antibiotics have been linked to long hospital stays, significant morbidity and mortality, increased medical costs and rising antimicrobial resistance (AMR). Statistics in hospitals involved in the study, showed increased antibiotic consumption compared to previous years and other regional healthcare faci...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All physicians with valid medical licenses working in Tawam and Al Ain tertiary hospitals
- Exclusion Criteria:
- • Infectious diseases physicians and Microbiologists
About Abu Dhabi Health Services Company
Abu Dhabi Health Services Company (SEHA) is a leading healthcare provider in the United Arab Emirates, committed to delivering high-quality medical services and advancing healthcare innovation. As a prominent sponsor of clinical trials, SEHA focuses on enhancing patient care through rigorous research and development initiatives. The organization collaborates with local and international partners to facilitate studies that address critical health challenges, ensuring adherence to the highest ethical and regulatory standards. By fostering an environment of scientific inquiry, SEHA aims to contribute to the global medical community and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Ain, , United Arab Emirates
Patients applied
Trial Officials
Noura Saif Alnuaimi, MD
Principal Investigator
Abu Dhabi Health Services Co-SEHA
Ahmed Al Hammadi, MD
Study Chair
Abu Dhabi Health Services Co-SEHA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported